Therapeutic potential for blockade of the CD40 ligand, gp39
Therapeutic potential for blockade of the CD40 ligand, gp39
复制标题
阻断 CD40 配体 gp39 的治疗潜力
DOI:
--
复制
发表时间:
1996
影响因子:
9.1
通讯作者:
R. Noelle
中科院分区:
文献类型:
--
作者:
J. Buhlmann;R. Noelle
ConclusionsThere is mounting evidence supporting a critical role for gp39-CD40 interactions in the development of both humoral and cellular immune responses. It has been shown that gp39 and CD40 are critical for the development and generation of antibody responses and memory B cells. Evidence for this ligand receptor pair being involved in other types of immune responses is constantly emerging. Experiments in the GVHD system as well as the ability of B cells to tolerize T cells in the presence of anti-gp39 suggest that gp39 and CD40 are also important for the generation of cellular immune responses. The effect on cellular immune responses may be through the control of costimulatory molecules necessary for proper antigen presentation and stimulation. It has been shown that CD40 can control costimulatory molecule expression on several types of antigen-presenting cells; this may be a critical step in the regulation of a cell's ability to present antigen. The role of gp39 and CD40 in the regulation of cytokines, nitric oxide production, and extravasation of cells is just being elucidated but this is potentially yet another tier of immune responses upon which gp39 may have a regulatory effect. Thus, because gp39-CD40 interactions are critical in both the efferent and the afferent arms of the immune response, this ligand-receptor pair is a highly attractive therapeutic target. Blockade of this interaction may lead to enhanced survival of allografts and transplants as well as potentially being able to inhibit a wide spectrum of autoimmune diseases.
登录
查看更多内容
DOI:
--
发表时间:
1993
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Hoffman,RA;Langrehr,JM;Wren,SM;Dull,KE;Ildstad,ST;McCarthy,SA;Simmons,RL
通讯作者:
Simmons,RL
DOI:
--
发表时间:
1994
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Mamula,MJ;Fatenejad,S;Craft,J
通讯作者:
Craft,J
DOI:
10.1172/jci117453
发表时间:
1994-09
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
F. H. Durie;A. Aruffo;J. Ledbetter;K. M. Crassi;W. Green;L. Fast;R. Noelle
通讯作者:
F. H. Durie;A. Aruffo;J. Ledbetter;K. M. Crassi;W. Green;L. Fast;R. Noelle
DOI:
10.1073/pnas.92.10.4342
发表时间:
1995-05-09
影响因子:
11.1
作者:
KARMANN, K;HUGHES, CCW;POBER, JS
通讯作者:
POBER, JS
DOI:
10.1073/pnas.91.25.12135
发表时间:
1994-12-06
影响因子:
11.1
作者:
CASTIGLI, E;ALT, FW;GEHA, RS
通讯作者:
GEHA, RS